CCBs vs ACE inhibitors in patients with diabetes
Zamorski, M.A.
Journal of Family Practice 47(1): 12-13
1998
ISSN/ISBN: 0094-3509 PMID: 9673598 Document Number: 493049
Document emailed within 1 workday
Related Documents
Chronister, C.L.; Gurwood, A.S. 1998: Type 2 diabetes in association with HIV-1 protease inhibitors in HIV-infected patients Journal of the American Optometric Association 69(11): 695-698Shetty, A.S.; Nandith, A.; Snehalath, C.; Ramachandran, A. 2013: Treatment with DPP-4 inhibitors does not increase the chance of pancreatitis in patients with type 2 diabetes Journal of the Association of Physicians of India 61(8): 543-544
Bonnici, F.; Omar, M.A. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors have a more beneficial effect on biochemical parameters than low-dose thiazides South African Medical Journal 80(5): Suppl 6
Dominguez, J.R.; de la Calle, H.; Hurtado, A.; Robles, R.G.; Sancho-Rof, J. 1986: Effect of converting enzyme inhibitors in hypertensive patients with non-insulin-dependent diabetes mellitus Postgraduate Medical Journal 62(Suppl 1): 66-68
Huddle, K.; Milne, F.J. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy South African Medical Journal 80(5): Suppl 10
Green, L.J..; Yamauchi, P.S..; Kircik, L.H.. 2019: Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients with Psoriasis Journal of Drugs in Dermatology: Jdd 18(8): 776-788
Marre, M. 1992: Converting enzyme inhibitors in diabetes La Revue du Praticien 42(20): 2574-2577
Hönl, S.B. 2008: Type 2 diabetes. Routine ACE inhibitors? Medizinische Monatsschrift für Pharmazeuten 31(4): 149-150
Nørgaard, K.; Vibe-Petersen, J.; Røjen, D.; Mølvig, J.C. 2007: Diabetes passport--understanding and use among different ethnic groups of diabetes patients. Interviews with Turkish, Pakistani and Danish patients Ugeskrift for Laeger 169(46): 3960-3965
Choi, J.-y.; Kwon, O.-K.; Choi, S.Y.; Park, Y.K.; Kim, S.S. 2011: Drug susceptibility of human immunodeficiency virus type 1-derived pseudoviruses from treatment-experienced patients to protease inhibitors and reverse transcriptase inhibitors, using a modified single-round assay Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 50(1): 19-25
Giorgino, R.; Damato, A. 1995: Alpha-Glucosidase inhibitors in the therapy of diabetes mellitus Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 10 Suppl: 61s-65s
Scheen, A.J. 2015: How i TREAT ... THE ROLE OF DPP-4 INHIBITORS (GLIPTINS) IN THE TREATMENT OF TYPE 2 DIABETES Revue Medicale de Liege 70(12): 593-599
Philips, J-Christophe.; Paquot, N.; Scheen, A.J. 2019: Potential role of SGLT2 inhibitors in the management of type 1 diabetes Revue Medicale Suisse 15(659): 1426-1430
Kawamori, R. 2011: The expectation for DPP-4 inhibitors on future treatment of type 2 diabetes mellitus Nihon Rinsho. Japanese Journal of Clinical Medicine 69(8): 1515-1519
Tiwaskar, M. 2019: INSIGHTS (INSITES) on DPP 4 Inhibitors (Gliptins) for Diabetes Management in India Journal of the Association of Physicians of India 67(10): 11-12
Overby, A. 1988: Control of the eyes in patients with diabetes (1). An annual examination of all patients with diabetes Lakartidningen 85(47): 4048-4049
Kuchmerovskaia, T.M.; Donchenko, G.V.; Klimenko, A.P.; Chichkovskaia, G.V.; Pakirbaeva, L.V.; Kozitskiĭ, Z.I.; Efimov, A.S. 1997: Role of aldose reductase inhibitors in the development of peripheral neuropathy in experimental diabetes Ukrainskii Biokhimicheskii Zhurnal 69(3): 77-82
Borysiuk, M.V. 2002: Changes in the activity of elastase and its inhibitors in the aorta tissue and blood serum of rats with streptozocin-induced diabetes Fiziolohichnyi Zhurnal 48(4): 47-52
Krawczuk-Rybak, M.; Wójtowicz, J.; Urban, M. 1992: Lipid metabolism in patients with insulin dependent diabetes. IV. Effect of sex, age, excess body weight, duration of diabetes, insulin dosage and family history on lipid metabolism in patients with insulin dependent diabetes Endokrynologia Polska 43(2): 125-135
Elorriaga-Sánchez, F.; Corrales-Bobadilla, H.; Sosa-Trinidad, E.; Domínguez-Quezada, B. 2001: Severe hypoglycemia secondary to angiotensin-converting-enzyme inhibitors in the absence of diabetes mellitus. Report of a case Gaceta Medica de Mexico 137(3): 249-252